Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd. has announced plans to raise up to Rs. 12,500 crore through the issuance of securities, signaling a strategic move to strengthen its financial flexibility amid an evolving pharmaceutical landscape. The proposed fundraising underscores the company’s intent to support long-term growth, enhance balance sheet resilience, and retain optionality for future investments or acquisitions.

Torrent Pharmaceuticals has been issued a Goods and Services Tax demand of Rs. 41 crore, intensifying regulatory pressures at a time when compliance scrutiny across India’s pharmaceutical sector is rising. The notice, which includes tax, interest, and penalties, underscores the growing assertiveness of tax authorities as they tighten enforcement under the GST framework. While Torrent Pharma has stated its intention to contest the claim, the development has stirred conversations around the industry’s complex tax structures and operational exposure.

Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals in a transaction valued at Rs. 19,500 crore—marking the second-largest merger in India’s pharmaceutical industry after Sun Pharma’s acquisition of Ranbaxy in 2015. The multi-phase deal includes promoter and employee share purchases, followed by an open market offer, and culminates in a merger of JB Pharma into Torrent.